141 related articles for article (PubMed ID: 22155287)
1. Stabilization of tetanus toxoid formulation containing aluminium hydroxide adjuvant against agitation.
Solanki VA; Jain NK; Roy I
Int J Pharm; 2012 Feb; 423(2):297-302. PubMed ID: 22155287
[TBL] [Abstract][Full Text] [Related]
2. Stabilization of tetanus toxoid formulation containing aluminium hydroxide adjuvant against freeze-thawing.
Solanki VA; Jain NK; Roy I
Int J Pharm; 2011 Jul; 414(1-2):140-7. PubMed ID: 21605644
[TBL] [Abstract][Full Text] [Related]
3. Preformulation characterization of an aluminum salt-adjuvanted trivalent recombinant protein-based vaccine candidate against Streptococcus pneumoniae.
Iyer V; Hu L; Liyanage MR; Esfandiary R; Reinisch C; Meinke A; Maisonneuve J; Volkin DB; Joshi SB; Middaugh CR
J Pharm Sci; 2012 Sep; 101(9):3078-90. PubMed ID: 22538529
[TBL] [Abstract][Full Text] [Related]
4. Structural perturbation of diphtheria toxoid upon adsorption to aluminium hydroxide adjuvant.
Régnier M; Metz B; Tilstra W; Hendriksen C; Jiskoot W; Norde W; Kersten G
Vaccine; 2012 Nov; 30(48):6783-8. PubMed ID: 23000120
[TBL] [Abstract][Full Text] [Related]
5. Stabilisation of vaccines using trehalose (Q-T4) technology.
Gribbon EM; Sen SD; Roser BJ; Kampinga J
Dev Biol Stand; 1996; 87():193-9. PubMed ID: 8854017
[TBL] [Abstract][Full Text] [Related]
6. Influences of excipients on in vitro release and in vivo performance of tetanus toxoid loaded polymer particles.
Katare YK; Panda AK
Eur J Pharm Sci; 2006 Jun; 28(3):179-88. PubMed ID: 16517132
[TBL] [Abstract][Full Text] [Related]
7. Optimization of the formulation for a candidate lyophilised tetanus toxoid reference preparation.
Matejtschuk P; Malik K; Tierney R; Sloth Wilhelmsen E; Preneta-Blanc R; Rigsby P; Sesardic D
Biologicals; 2009 Jan; 37(1):1-7. PubMed ID: 18805022
[TBL] [Abstract][Full Text] [Related]
8. Characterisation of protein stability in rod-insert vaginal rings.
Pattani A; Lowry D; Curran RM; McGrath S; Kett VL; Andrews GP; Malcolm RK
Int J Pharm; 2012 Jul; 430(1-2):89-97. PubMed ID: 22486955
[TBL] [Abstract][Full Text] [Related]
9. A method of lyophilizing vaccines containing aluminum salts into a dry powder without causing particle aggregation or decreasing the immunogenicity following reconstitution.
Li X; Thakkar SG; Ruwona TB; Williams RO; Cui Z
J Control Release; 2015 Apr; 204():38-50. PubMed ID: 25735896
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of aggregation of aluminum hydroxide adjuvant during freezing and drying.
Clausi AL; Merkley SA; Carpenter JF; Randolph TW
J Pharm Sci; 2008 Jun; 97(6):2049-61. PubMed ID: 17879291
[TBL] [Abstract][Full Text] [Related]
11. Improved formulation of a recombinant ricin A-chain vaccine increases its stability and effective antigenicity.
Carra JH; Wannemacher RW; Tammariello RF; Lindsey CY; Dinterman RE; Schokman RD; Smith LA
Vaccine; 2007 May; 25(21):4149-58. PubMed ID: 17408819
[TBL] [Abstract][Full Text] [Related]
12. Stabilization of dichloromethane-induced protein denaturation during microencapsulation.
Raghuvanshi RS; Goyal S; Singh O; Panda AK
Pharm Dev Technol; 1998 May; 3(2):269-76. PubMed ID: 9653765
[TBL] [Abstract][Full Text] [Related]
13. Immune response to antigen adsorbed to aluminum hydroxide particles: Effects of co-adsorption of ALF or ALFQ adjuvant to the aluminum-antigen complex.
Beck Z; Torres OB; Matyas GR; Lanar DE; Alving CR
J Control Release; 2018 Apr; 275():12-19. PubMed ID: 29432824
[TBL] [Abstract][Full Text] [Related]
14. Enhanced mucosal immune responses against tetanus toxoid using novel delivery system comprised of chitosan-functionalized gold nanoparticles and botanical adjuvant: characterization, immunogenicity, and stability assessment.
Barhate G; Gautam M; Gairola S; Jadhav S; Pokharkar V
J Pharm Sci; 2014 Nov; 103(11):3448-3456. PubMed ID: 25219511
[TBL] [Abstract][Full Text] [Related]
15. Comparison of oil adjuvant and aluminium phosphate-adsorbed toxoid for the passive immunization of lambs against tetanus.
Cameron CM; Van Biljon BJ; Botha WJ; Knoetze PC
Onderstepoort J Vet Res; 1983 Sep; 50(3):229-31. PubMed ID: 6646665
[TBL] [Abstract][Full Text] [Related]
16. Immunoenhancement with combined rabies and aluminium-adjuvanted tetanus vaccines.
Phanuphak P; Khaoplod P; Sriwanthana B; Phanpanich T; Wongurai S; Roumiantzeff M
Vaccine; 1989 Jun; 7(3):249-52. PubMed ID: 2781858
[TBL] [Abstract][Full Text] [Related]
17. Calibration of the Ph. Eur. Biological Reference Preparation (BRP) for tetanus vaccine (adsorbed) batch 3.
Tierney R; Hockley J; Rigsby P; Terao E; Daas A; Buchheit KH; Sesardic D
Pharmeur Bio Sci Notes; 2011 Jun; 2011(1):1-26. PubMed ID: 21619853
[TBL] [Abstract][Full Text] [Related]
18. Quantitative Analysis of Vaccine Antigen Adsorption to Aluminum Adjuvant Using an Automated High-Throughput Method.
Ahl PL; Wang SC; Chintala R; Mensch C; Smith WJ; Wenger M; Blue J
PDA J Pharm Sci Technol; 2018; 72(2):149-162. PubMed ID: 29343619
[TBL] [Abstract][Full Text] [Related]
19. Physiochemical and functional characterization of antigen proteins eluted from aluminum hydroxide adjuvant.
Hutcheon CJ; Becker JO; Russell BA; Bariola PA; Peterson GJ; Stroop SD
Vaccine; 2006 Nov; 24(49-50):7214-25. PubMed ID: 16860908
[TBL] [Abstract][Full Text] [Related]
20. Stimulating role of toxoids-laden liposomes in oral immunization against diphtheria and tetanus infections.
Mirchamsy H; Manhouri H; Hamedi M; Ahourai P; Fateh G; Hamzeloo Z
Biologicals; 1996 Dec; 24(4):343-50. PubMed ID: 9088551
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
